178 related articles for article (PubMed ID: 23113715)
1. CA15.3, CEA and LDH in dogs with malignant mammary tumors.
Campos LC; Lavalle GE; Estrela-Lima A; Melgaço de Faria JC; Guimarães JE; Dutra ÁP; Ferreira E; de Sousa LP; Rabelo ÉM; Vieira da Costa AF; Cassali GD
J Vet Intern Med; 2012; 26(6):1383-8. PubMed ID: 23113715
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of carcinoembryonic antigen in mammary neoplasms of bitches.
Senhorello ILS; Terra EM; Sueiro FAR; Firmo BF; Anai LA; Goloni C; Canavari IC; Ampuero RAN; Pereira RS; Tinucci-Costa M
Vet Comp Oncol; 2020 Sep; 18(3):315-323. PubMed ID: 31664787
[TBL] [Abstract][Full Text] [Related]
3. Determination of carcinoembryonic antigen and cancer antigen (CA 15-3) in bitches with tumours on mammary gland: preliminary report.
Valencakova-Agyagosova A; Frischova Z; Sevcikova Z; Hajurka J; Lepej J; Szakallova I; Kredatusova G; Nagy V; Ledecky V
Vet Comp Oncol; 2014 Sep; 12(3):205-14. PubMed ID: 22947252
[TBL] [Abstract][Full Text] [Related]
4. Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients.
Fan Y; Ren X; Liu X; Shi D; Xu E; Wang S; Liu Y
Sci Rep; 2021 Mar; 11(1):6651. PubMed ID: 33758208
[TBL] [Abstract][Full Text] [Related]
5. HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients.
Zeiwar MM; Zaki SM; Mohammad LA; Zidan AA; El Nagar MR
Egypt J Immunol; 2007; 14(2):29-41. PubMed ID: 20306655
[TBL] [Abstract][Full Text] [Related]
6. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
[TBL] [Abstract][Full Text] [Related]
7. Plasma biomarkers profile of female dogs with mammary carcinoma and its association with clinical and pathological features.
Estrela-Lima A; Araújo MS; Soares RP; Ribeiro LG; Damasceno KA; Costa AT; Teixeira-Carvalho A; Martins-Filho OA; Cassali GD
Vet Comp Oncol; 2016 Mar; 14(1):88-100. PubMed ID: 24571435
[TBL] [Abstract][Full Text] [Related]
8. Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer.
Shao Y; Sun X; He Y; Liu C; Liu H
PLoS One; 2015; 10(7):e0133830. PubMed ID: 26207909
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of tissue and serum HER2 and MUC1 in canine mammary cancer.
Campos LC; Silva JO; Santos FS; Araújo MR; Lavalle GE; Ferreira E; Cassali GD
J Vet Diagn Invest; 2015 Jul; 27(4):531-5. PubMed ID: 26179096
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.
Samy N; Ragab HM; El Maksoud NA; Shaalan M
Cancer Biomark; 2010; 6(2):63-72. PubMed ID: 20571232
[TBL] [Abstract][Full Text] [Related]
11. Loss of p27 expression in canine mammary tumors and their metastases.
Klopfleisch R; Schütze M; Gruber AD
Res Vet Sci; 2010 Apr; 88(2):300-3. PubMed ID: 19748645
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serum haptoglobin and C-reactive protein in dogs with mammary tumors.
Planellas M; Bassols A; Siracusa C; Saco Y; Giménez M; Pato R; Pastor J
Vet Clin Pathol; 2009 Sep; 38(3):348-52. PubMed ID: 19392756
[TBL] [Abstract][Full Text] [Related]
13. Serum neopterin levels in female dogs with malignant mammary tumours.
Szczubiał M; Dąbrowski R; Łopuszyński W
Vet Comp Oncol; 2014 Jun; 12(2):143-8. PubMed ID: 22882538
[TBL] [Abstract][Full Text] [Related]
14. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
[TBL] [Abstract][Full Text] [Related]
15. Comparison of serum CA15-3 and CEA in breast cancer.
Hou MF; Huang TJ; Hsieh JS; Huang YS; Huang CJ; Chan HM; Wang JY; Chen YL; Jong SB; Yang CC
Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Dec; 11(12):660-6. PubMed ID: 8551526
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a novel assay for breast cancer mucin to CA15-3 and carcinoembryonic antigen.
Daly L; Ferguson J; Cram GP; Hars V; George SL; McCarty KS; Bast RC
J Clin Oncol; 1992 Jul; 10(7):1057-65. PubMed ID: 1607912
[TBL] [Abstract][Full Text] [Related]
17. Combined measurement of serum sialyl Lewis X with serum CA15-3 in breast cancer patients.
Kurebayashi J; Nomura T; Hirono M; Okubo S; Udagawa K; Shiiki S; Ikeda M; Nakashima K; Tanaka K; Sonoo H
Jpn J Clin Oncol; 2006 Mar; 36(3):150-3. PubMed ID: 16520359
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of an immunoradiometric assay for CA15-3 antigen associated with human mammary carcinomas: comparison with carcinoembryonic antigen.
Fujino N; Haga Y; Sakamoto K; Egami H; Kimura M; Nishimura R; Akagi M
Jpn J Clin Oncol; 1986 Dec; 16(4):335-46. PubMed ID: 3467106
[TBL] [Abstract][Full Text] [Related]
19. Changes in serum neopterin and C-reactive protein concentrations in female dogs with mammary gland tumours.
Szczubiał M; Dabrowski R; Łopuszyński W; Bochniarz M; Krawczyk M
Pol J Vet Sci; 2018 Dec; 21(4):691-696. PubMed ID: 30605283
[TBL] [Abstract][Full Text] [Related]
20. Assessing Clinical Significance of Serum CA15-3 and Carcinoembryonic Antigen (CEA) Levels in Breast Cancer Patients: A Meta-Analysis.
Fu Y; Li H
Med Sci Monit; 2016 Sep; 22():3154-62. PubMed ID: 27596019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
